全新出炉:57名医药人当选第十三届全国人大代表、政协委员

2018-02-12 一票人马 E药经理人

近日,政协第十三届全国委员名单和第十三届全国人大代表名单陆续公布,医药界新当选的医药界全国人大代表政协委员引人关注。

还有不到一个月,我们即将迎来第十三届全国人民代表大会第一次会议和政协第十三届全国委员会第一次会议

近日,政协第十三届全国委员名单和第十三届全国人大代表名单陆续公布,医药界新当选的医药界全国人大代表政协委员引人关注。

据不完全统计,第十三届全国人大代表来自医药界的共计33人。其中,连任的代表有17位,占52%;楚天科技董事长唐岳、中国医疗器械董事长于清明、齐鲁制药总经理李燕、东阿阿胶总经理秦玉峰、以岭药业总经理吴相君等16位医药企业家首次当选。

据不完全统计,第十三届全国政协委员来自医药界的共计24位。其中,连任的委员有10位,占42%;天津康希诺联合创始人朱涛、深圳海王集团总裁张峰、义翘神州总裁及首席执行官谢良志、哈尔滨誉衡药业董事长朱吉满、悦康药业总裁于圣臣等医药企业家首次当选。

据悉,由中国医药企业管理协会等中国医药行业25家协/学会联合打造的中国医药行业最富影响力的“高端话语策源地”——第十届“声音·责任”医药界全国人大代表政协委员座谈会将于3月4日在北京召开,届时,新当选的医药界全国人大代表政协委员将受邀与会,为我国医药行业健康持续发展建言献策,贡献力量。

附医药界第十三届全国人大代表政协委员不完全名单



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1914075, encodeId=d89a19140e556, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Thu Mar 15 20:19:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288408, encodeId=b47b28840843, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Fri Feb 16 14:05:31 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409354, encodeId=677f140935493, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469590, encodeId=dd6014695905a, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627056, encodeId=efa6162e056d4, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287420, encodeId=2c0a28e42010, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Feb 12 20:39:41 CST 2018, time=2018-02-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1914075, encodeId=d89a19140e556, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Thu Mar 15 20:19:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288408, encodeId=b47b28840843, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Fri Feb 16 14:05:31 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409354, encodeId=677f140935493, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469590, encodeId=dd6014695905a, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627056, encodeId=efa6162e056d4, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287420, encodeId=2c0a28e42010, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Feb 12 20:39:41 CST 2018, time=2018-02-12, status=1, ipAttribution=)]
    2018-02-16 飘飘爱

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1914075, encodeId=d89a19140e556, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Thu Mar 15 20:19:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288408, encodeId=b47b28840843, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Fri Feb 16 14:05:31 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409354, encodeId=677f140935493, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469590, encodeId=dd6014695905a, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627056, encodeId=efa6162e056d4, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287420, encodeId=2c0a28e42010, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Feb 12 20:39:41 CST 2018, time=2018-02-12, status=1, ipAttribution=)]
    2018-02-14 hb2008ye
  4. [GetPortalCommentsPageByObjectIdResponse(id=1914075, encodeId=d89a19140e556, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Thu Mar 15 20:19:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288408, encodeId=b47b28840843, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Fri Feb 16 14:05:31 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409354, encodeId=677f140935493, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469590, encodeId=dd6014695905a, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627056, encodeId=efa6162e056d4, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287420, encodeId=2c0a28e42010, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Feb 12 20:39:41 CST 2018, time=2018-02-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1914075, encodeId=d89a19140e556, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Thu Mar 15 20:19:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288408, encodeId=b47b28840843, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Fri Feb 16 14:05:31 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409354, encodeId=677f140935493, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469590, encodeId=dd6014695905a, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627056, encodeId=efa6162e056d4, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287420, encodeId=2c0a28e42010, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Feb 12 20:39:41 CST 2018, time=2018-02-12, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1914075, encodeId=d89a19140e556, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Thu Mar 15 20:19:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288408, encodeId=b47b28840843, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Fri Feb 16 14:05:31 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409354, encodeId=677f140935493, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469590, encodeId=dd6014695905a, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627056, encodeId=efa6162e056d4, content=<a href='/topic/show?id=c9f65e45389' target=_blank style='color:#2F92EE;'>#政协委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57453, encryptionId=c9f65e45389, topicName=政协委员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbf21082352, createdName=dingxiaobo, createdTime=Wed Feb 14 08:19:00 CST 2018, time=2018-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287420, encodeId=2c0a28e42010, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Feb 12 20:39:41 CST 2018, time=2018-02-12, status=1, ipAttribution=)]
    2018-02-12 131****1460

    学习了受益匪浅

    0

相关资讯

“声音·责任”2016医药界全国人大代表政协委员座谈会实录

会议主题:2016医药界全国人大代表政协委员座谈会 会议时间:2016年3月4日(下午) 会议地点:北京国宾 主持人:各位代表、领导,来自媒体的各位朋友,我是许铭,是今天下午会议的主持人。今天下午的会议,声音责任,2016两会医药界代表座谈会正式开始。声音承载着人民群众的希望,责任勇于为国家振兴而担当。民众企业有所呼,代表委员敢于应,行业发展有所需,代表委员敢于议。出席今天座

全国人大代表瞿佳:不重视医生的医改就是句空话

“医改最突出的矛盾在于医生。”瞿佳代表告诉记者,“中央、各级政府都应重视,否则医改就是一句空话。”作为一名医学研究者和教育者,曾任温州医科大学校长的瞿佳代表在担任第十二届全国人大代表的这些年,一直围绕着基层医生的培养使用提出建议。上述这句话,他在很多场合都说过,今年又更添深意。从2014年起,瞿佳就一直在建议,解决“看病难”问题,应做好“国标、省统、县管、乡用”,即在基层全科医生的培养和使用上要做

凑热闹:除了人大代表,两会还看什么?

每年的两会都是全国关注的重点,全国政协十二届四次会议于今天下午在北京召开,十二届全国人大四次会议将于后天召开。 两会最受关注的肯定是来自五湖四海的人民代表们,但仍有那么一群人,在两会期间我们会频繁地听到他们的名称,却很少能记住他们,可是对于许多人大代表们来说,这群人却是他们对两会的深刻认识之一。 一、摄影师 摄影师们常常藏身于摄像头之后,来看看今年在两会期间他们带来的

人大代表王浩公:戒烟治疗应纳入医保

人大代表王浩公今年第一次参加省两会,他带着29项建议,涉及防治重大雪情立法、污水治理、公共场所禁烟、物业监管等一系列民生问题。